Capital Research Global Investors
IBRX icon

Capital Research Global Investors’s ImmunityBio IBRX Stock Holding History

Capital Research Global Investors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,660,990
Closed -$9.85M – 427
2018
Q3 		$9.85M Hold
2,660,990
– – ﹤0.01% 412
2018
Q2 		$8.14M Hold
2,660,990
– – ﹤0.01% 416
2018
Q1 		$10.4M Hold
2,660,990
– – ﹤0.01% 417
2017
Q4 		$11.9M Hold
2,660,990
– – ﹤0.01% 403
2017
Q3 		$14.6M Hold
2,660,990
– – ﹤0.01% 395
2017
Q2 		$20.2M Hold
2,660,990
– – 0.01% 384
2017
Q1 		$9.45M Hold
2,660,990
– – ﹤0.01% 406
2016
Q4 		$15.2M Hold
2,660,990
– – ﹤0.01% 392
2016
Q3 		$20.7M Hold
2,660,990
– – 0.01% 373
2016
Q2 		$16.6M Hold
2,660,990
– – 0.01% 375
2016
Q1 		$21.9M Hold
2,660,990
– – 0.01% 373
2015
Q4 		$45.2M Hold
2,660,990
– – 0.02% 336
2015
Q3 		$29.7M Buy
+2,660,990
New +$58.1M 0.01% 368

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HK
Horizon Kinetics New York $2.96B AUM 5.37% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return